Cardiovascular disease, e.g., congestive heart failure, is often first diagnosed after the onset of clinical symptoms, eliminating potential for early intervention. The invention provides a multi-marker immunoassay, including cardiac pathology and vascular inflammation biomarkers, yielding a more se
Cardiovascular disease, e.g., congestive heart failure, is often first diagnosed after the onset of clinical symptoms, eliminating potential for early intervention. The invention provides a multi-marker immunoassay, including cardiac pathology and vascular inflammation biomarkers, yielding a more sensitive assay for early detection of CHF in plasma. A panel consisting of cardiac pathology (cTnI, BNP) and vascular inflammation (IL-6, TNFα, IL-17a) biomarkers provided a sensitivity of 94% for association with CHF.
대표청구항▼
1. A method for detecting or monitoring a cardiovascular condition associated with cardiomyocyte damage in a subject, comprising detecting the concentration of two or more biomarkers in a sample from the subject, wherein the biomarkers comprise Troponin-I (cTnI) and Interleukin 17a (IL-17a), and whe
1. A method for detecting or monitoring a cardiovascular condition associated with cardiomyocyte damage in a subject, comprising detecting the concentration of two or more biomarkers in a sample from the subject, wherein the biomarkers comprise Troponin-I (cTnI) and Interleukin 17a (IL-17a), and wherein the limit of detection of at least one biomarker is less than about 20 pg/ml, comparing the concentration of the biomarkers to threshold concentrations for the biomarkers, and determining the presence of the cardiovascular condition when the concentration of the biomarkers in the sample is greater than the threshold concentrations. 2. The method of claim 1, wherein the detection of the concentration of the at least one biomarker having the limit of detection less than about 20 pg/ml comprises contacting the sample with a label for the marker and detecting the level of the label that becomes associated with the at least one biomarker. 3. The method of claim 2, wherein the label comprises a fluorescent moiety, and the at least one biomarker having the limit of detection less that about 20 pg/ml is detected in an interrogation space comprising a label corresponding to a single molecule of the biomarker. 4. The method of claim 2, wherein the label comprises a fluorescent moiety, and the detection comprises passing the label through a single molecule detector, wherein the single molecule detector comprises: (a) an electromagnetic radiation source for stimulating the fluorescent moiety;(b) an interrogation space for receiving electromagnetic radiation emitted from the electromagnetic source; and(c) an electromagnetic radiation detector operably connected to the interrogation space for determining an electromagnetic characteristic of the stimulated fluorescent moiety. 5. The method of claim 1, wherein the limit of detection of at least one marker ranges from about 10 pg/ml to about 0.01 pg/ml. 6. The method of claim 1, wherein cardiovascular condition comprises congestive heart failure and the two or more biomarkers further comprise at least one of B-type Natriuretic Peptide (BNP), proBNP and NT-proBNP, and Tumor Necrosis Factor alpha (TNF-α). 7. A method for detecting congestive heart failure in a subject, comprising detecting whether the level of two or more members of a panel of biomarkers in a sample from a subject are elevated compared to the level of the two or more biomarkers in a normal population, wherein the members of the panel comprise Troponin-I (cTnI) and Interleukin 17a (IL-17a), and wherein the limit of detection of at least one member of the panel is less than about 20 pg/ml. 8. The method of claim 7, wherein the at least one member of the panel having a detection limit less than about 20 pg/ml is cTnI. 9. The method of claim 7, wherein the detection of the level of the at least one biomarker comprises contacting the sample with a label for the at least one biomarker and detecting the level of the label that becomes associated with the at least one biomarker. 10. The method of claim 7, wherein the label comprises a fluorescent moiety, and the at least one biomarker having the limit of detection less that about 20 pg/ml is detected in an interrogation space comprising a label corresponding to a single molecule of the biomarker. 11. The method of claim 7, wherein the label comprises a fluorescent moiety, and the detection comprises passing the label through a single molecule detector, wherein the single molecule detector comprises: (a) an electromagnetic radiation source for stimulating the fluorescent moiety;(b) an interrogation space for receiving electromagnetic radiation emitted from the electromagnetic source; and(c) an electromagnetic radiation detector operably connected to the interrogation space for determining an electromagnetic characteristic of the stimulated fluorescent moiety. 12. The method of claim 11, wherein the limit of detection of at least one marker ranges from about 10 pg/ml to about 0.01 pg/ml. 13. The method of claim 1, wherein the two or more biomarkers further comprises at least one of B-type Natriuretic Peptide (BNP), proBNP and NT-proBNP, and Tumor Necrosis Factor alpha (TNF-α). 14. The method of claim 7, wherein the members of the panel further comprise at least one of B-type Natriuretic Peptide (BNP), proBNP and NT-proBNP, and Tumor Necrosis Factor alpha (TNF-α). 15. The method of claim 13, wherein the members of the panel further comprise Interleukin 6 (IL-6). 16. The method of claim 14, wherein the members of the panel further comprise Interleukin 6 (IL-6). 17. The method of claim 1, wherein the cardiovascular condition associated with cardiomyocyte damage is selected from the group consisting of congestive heart failure (CHF), atherosclerosis, angina pectoris, atrial fibrillation, myocardial ischernia, myocardial infarction, myocarditis, hypertrophic cardiomyopathy and cholesterol embolism.
연구과제 타임라인
LOADING...
LOADING...
LOADING...
LOADING...
LOADING...
이 특허에 인용된 특허 (157)
Heller Michael J. (Encinitas CA) Tu Eugene (San Diego CA), Active programmable electronic devices for molecular biological analysis and diagnostics.
Chang, Richard K.; Pan, Young-Le; Pinnick, Ronald G.; Hill, Steven C., Aerosol fluorescence spectrum analyzer for rapid measurement of single airborne particles.
Crosby,Peter A.; Morris,Deborah L.; Soane,Mark M., Apparatus and method for risk stratification of patients with chest pain of suspected cardiac origin.
Baer Thomas M. (Mountain View CA) Dietz Louis J. (Mountain View CA) Dubrow Robert S. (San Carlos CA) Hayter Paul G. (Los Altos CA) Hodges Michael (Palo Alto CA) Manian Bala S. (Los Altos Hills CA) Sh, Apparatus and method for volumetric capillary cytometry.
Groman Ernest V. (Brookline MA) Josephson Lee (Arlington MA), Biologically degradable superparamagnetic particles for use as nuclear magnetic resonance imaging agents.
Mathies Richard A. (Contra Costa County CA) Huang Xiaohua C. (Santa Clara County CA) Quesada Mark A. (San Francisco County CA), Capillary array confocal fluorescence scanner and method.
Serena,Joaqu��n; Dāvalos,Antoni; Castellanos,Mar; Castillo,Jos��; Diamond,Cornelius Allen, Cellular fibronectin as a diagnostic marker in stroke and methods of use thereof.
Chow Calvin Y. H. ; Parce John Wallace ; McReynolds Richard J. ; Kennedy Colin B. ; Bousse Luc J., Controller/detector interfaces for microfluidic systems.
Bergmann, Andreas; Morgenthaler, Nils; Papassotiriou, Jana; Struck, Joachim; Ng, Leong L., Diagnosis and risk classification of acute coronary syndrome by means of CT-proET-1 in combination with NT-proBNP.
Bergmann, Andreas; Morgenthaler, Nils; Papassotiriou, Jana; Struck, Joachim; Anker, Stefan, Diagnosis and risk stratification of cardiac insufficiency by means of natriuretic peptides for NYHA I patients.
Valkirs, Gunars E.; Dahlen, Jeffrey R.; Kirchick, Howard J.; Buechler, Kenneth F., Diagnostic markers of stroke and cerebral injury and methods of use thereof.
Hoffman Michael A. (Carmel CA), Fluorescent-particle analyzer with timing alignment for analog pulse subtraction of fluorescent pulses arising from diff.
Wada, H. Garrett; Kopf-Sill, Anne R.; Alajoki, Marja Liisa; Parce, J. Wallace; Wang, Benjamin N.; Chow, Andrea W.; Dubrow, Robert S., Focusing of microparticles in microfluidic systems.
Swedberg Sally A. (Los Altos CA) Kaltenbach Patrick (Bischweier DEX) Witt Klaus E. (Keltern DEX) Bek Fritz (Waldbronn DEX) Mittelstadt Laurie S. (Belmont CA), Fully integrated miniaturized planar liquid sample handling and analysis device.
Dollinger Gavin D. (San Francisco CA) Cunico Robert L. (Hercules CA) Kunitani Michael G. (San Rafael CA), HPLC light scattering detector for biopolymers.
Mathies Richard A. (Contra Costa County CA) Peck Konan (Contra Costa County CA) Stryer Lubert (Santa Clara County CA), High sensitivity fluorescent single particle and single molecule detection apparatus and method.
Ambrose W. Patrick ; Grace W. Kevin ; Goodwin Peter M. ; Jett James H. ; Orden Alan Van ; Keller Richard A., High throughput analysis of samples in flowing liquid.
Goix, Philippe J.; Puskas, Robert; Todd, John; Livingston, Richard A.; Held, Douglas; Wu, Alan, Highly sensitive system and method for analysis of troponin.
Goix, Philippe; Puskas, Robert; Todd, John; Livingston, Richard; Held, Douglas; Wu, Allan H. B., Highly sensitive system and method for analysis of troponin.
Goix, Philippe J.; Puskas, Robert; Todd, John; Livingston, Richard A.; Held, Douglas; Wu, Alan, Highly sensitive system and methods for analysis of troponin.
Bergmann, Andreas; Ernst, Andrea; Hampel, Harald, In vitro multiparameter determination method for the diagnosis and early diagnosis of neurodegenerative disorders.
Witt Klaus E. (Keltern DEX) Kaltenbach Patrick (Bischweier DEX) Bek Fritz (Waldbronn DEX) Swedberg Sally A. (Los Altos CA) Mittelstadt Laurie S. (Belmont CA), Low voltage miniaturized column analytical apparatus and method.
Miltenyi Stefan (Moitzfeld 60a ; D-5060 Bergisch Gladbach 1 Cologne DEX) Radbruch Andreas (Bonn DEX) Weichel Walter (Cologne DEX) Muller Werner (Cologne DEX) Gottlinger Christoph (Cologne DEX) Meyer , Metal matrices for use in high gradient magnetic separation of biological materials and method for coating the same.
Begg Geoffrey Stephen (Heidelberg AUX) Simpson Richard John (Richmond AUX) Burgess Antony Wilks (Camberwell AUX), Method allowing sequential chemical reactions.
Purvis ; Jr. Norman B. (1010 Lawnview Ct. Franklin TN 37064) Giorgio Todd D. (3608 Westbrook Dr. Nashville TN 37205), Method and apparatus for determining absolute particle size, surface area and volume normalized fluorescence using forwa.
Cherukuri Satyam C. (Cranbury NJ) Demers Robert R. (Cranbury NJ) Fan Zhong H. (Middlesex NJ) Levine Aaron W. (Lawrenceville NJ) McBride Sterling E. (Lawrence Township ; Mercer County NJ) Zanzucchi Pe, Method and system for inhibiting cross-contamination in fluids of combinatorial chemistry device.
Bergmann, Andreas, Method for controlling the therapy of patients suffering from cardiac insufficiency by means of in vitro determination of threshold values of vasoactive peptides.
Bergmann, Andreas; Papassotiriou, Jana; Struck, Joachim; Morgenthaler, Nils; Anker, Stefan, Method for determining amino-terminal proANP in patients having a cardiac disease or being suspected of developing or having a cardiac disease.
Seidel Claus,DEX ; Gunther Rolf,DEX ; Lupke Stefan,DEX, Method for differentiating or detecting particles in a sample by identifying signal segments of time-resolved, optical raw signals from the sample on the basis of single photon detection.
Goix, Philippe J.; Puskas, Robert; Todd, John; Livingston, Richard A.; Held, Douglas, Method for highly sensitive detection of single protein molecules labeled with fluorescent moieties.
Bergmann, Andreas; Struck, Joachim, Method for the determination of the formation of endothelins for medical diagnostic purposes, and antibodies and kits for carrying out such a method.
Bergmann, Andreas; Struck, Joachim, Method for the determination of the formation of endothelins for medical diagnostic purposes, and antibodies and kits for carrying out such a method.
Robotti, Karla M.; Yin, Hongfeng, Methods and using chemico-mechanical microvalve devices for the selective separation of components from multi-component fluid samples.
Buechler,Kenneth F.; McPherson,Paul H., Methods for the assay of troponin I and T and complexes of troponin I and T and selection of antibodies for use in immunoassays.
Bergmann, Andreas; Struck, Joachim; Morgenthaler, Nils G., Methods for the diagnosis and treatment of critically ill patients with endothelin, endothelin agonists and adrenomedullin antagonists.
Richard A. Mathies ; Pankaj Singhal ; Jin Xie ; Alexander N. Glazer, Microfabricated capillary electrophoresis chip and method for simultaneously detecting multiple redox labels.
Kaltenbach Patrick,DEX ; Swedberg Sally A. ; Witt Klaus E.,DEX ; Bek Fritz,DEX ; Mittelstadt Laurie S., Miniaturized planar columns for use in a liquid phase separation apparatus.
Kaltenbach Patrick (Bischweier DEX) Swedberg Sally A. (Los Altos CA) Witt Klaus E. (Keltern DEX) Bek Fritz (Waldbronn DEX) Mittelstadt Laurie S. (Belmont CA), Miniaturized planar columns in novel support media for liquid phase analysis.
Bottomley Paul A. (Clifton Park NY) Edelstein William A. (Schenectady NY), NMR Imaging of the transverse relaxation time using multiple spin echo sequences.
Hollis Mark A. (Concord MA) Ehrlich Daniel J. (Lexington MA) Murphy R. Allen (Boxboro MA) Kosicki Bernard B. (Acton MA) Rathman Dennis D. (Ashland MA) Chen Chang-Lee (Sudbury MA) Mathews Richard H. (, Optical and electrical methods and apparatus for molecule detection.
Poliak, Juraj; Gramiger, Jean; Nicati, Pierre-Alain; Ganyi, Tibor, Receiver designed to pick up an electromagnetic signal and system using such a receiver.
Goodwin Peter M. ; Jett James H. ; Keller Richard A. ; Van Orden Alan K. ; Machara Nicholas P., Single molecule identification using selected fluorescence characteristics.
Galambos, Paul C.; Okandan, Murat; Montague, Stephen; Smith, James H.; Paul, Phillip H.; Krygowski, Thomas W.; Allen, James J.; Nichols, Christopher A.; Jakubczak, II, Jerome F., Surface-micromachined microfluidic devices.
Doth Margit,DEX ; Petry Christoph,DEX, Synthetic calibrators for use in immunoassays, comprising the analytes or partial sequences thereof which are conjugated to inert carrier molecules.
Myers Stephen A. (25 Nimitz Pl. Old Greenwich CT 06870), System and method for determining changes in fluorescence of stained nucleic acid in electrophoretically separated bands.
Muller Ralph,DEX ; Sauer Markus,DEX ; Zander Christoph,DEX, System for distinguishing fluorescent molecule groups by time resolved fluorescence measurement.
Zeiher, Andreas M.; Heeschen, Christopher; Dimmeler, Stefanie; Hamm, Christian, sCD40L and placental growth factor (PLGF) used as a biochemical marker combination in cardiovascular diseases.
Goix, Philippe J.; Puskas, Robert; Todd, John; Livingston, Richard; Held, Douglas; Wu, Allan H. B., Highly sensitive system and method for analysis of troponin.
Goix, Philippe; Puskas, Robert; Todd, John; Livingston, Richard; Held, Douglas; Wu, Allan H. B., Highly sensitive system and method for analysis of troponin.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.